Thomas Kabir

ORCID: 0000-0001-8908-0964
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Mental Health Research Topics
  • Digital Mental Health Interventions
  • Mental Health Treatment and Access
  • Psychosomatic Disorders and Their Treatments
  • Mental Health and Psychiatry
  • Mental Health and Patient Involvement
  • COVID-19 and Mental Health
  • Virtual Reality Applications and Impacts
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Policy Implementation Science
  • Art Therapy and Mental Health
  • Family Caregiving in Mental Illness
  • Telemedicine and Telehealth Implementation
  • Ethics in Clinical Research
  • Eating Disorders and Behaviors
  • Psychotherapy Techniques and Applications
  • Sleep and related disorders
  • Long-Term Effects of COVID-19
  • Treatment of Major Depression
  • Empathy and Medical Education
  • Psychological and Temporal Perspectives Research
  • Pharmacovigilance and Adverse Drug Reactions
  • Health, psychology, and well-being
  • Optimism, Hope, and Well-being

McPin Foundation
2017-2024

University of Oxford
2023-2024

Oxford Health NHS Foundation Trust
2023-2024

University of Bath
2024

King's College London
2011-2024

Medway School of Pharmacy
2024

University of Nottingham
2024

The London College
2024

University of Otago
2024

Self-harm and eating disorders share multiple risk factors, with onset typically during adolescence or early adulthood. We aimed to examine the incidence rates of these psychopathologies among young people in UK 2 years following COVID-19 pandemic.We conducted a population-based study using primary care electronic health records patients aged 10-24 Clinical Practice Research Datalink (CPRD). The observation period was from Jan 1, 2010, March 31, 2022. calculated monthly self-harm according...

10.1016/s2352-4642(23)00126-8 article EN cc-by The Lancet Child & Adolescent Health 2023-06-20

BackgroundThere is a large clinical need for improved treatments patients with persecutory delusions. We aimed to test whether new theoretically driven cognitive therapy (the Feeling Safe Programme) would lead reductions in delusions, above non-specific effects of therapy. also treatment effect mechanisms.MethodsWe did parallel, single-blind, randomised controlled trial the Programme against befriending same therapists persistent delusions context non-affective psychosis diagnoses. Usual...

10.1016/s2215-0366(21)00158-9 article EN cc-by The Lancet Psychiatry 2021-07-08

Mental health problems bring substantial individual, community and societal costs the need for innovation to promote good mental prevent treat has never been greater. However, we know that research findings can take up 20 years implement. One way push pace is focus researchers funders on shared, specific goals targets. We describe a consultation process organised by Department of Health Social Care convened Chief Medical Officer consider high level future efforts begin identify UK-specific...

10.1080/09638237.2021.1898552 article EN cc-by-nc-nd Journal of Mental Health 2021-05-09

Many patients with psychosis experience everyday social situations as anxiety-provoking. The fears can arise, for example, from paranoia, hallucinations, anxiety or negative-self beliefs. lead to withdraw activities, and this isolation leads a cycle of worsening physical mental health. Breaking requires highly active treatment directly in the troubling so that learn they safely confidently enter them. However seldom receive such life-changing interventions. To solve problem we have developed...

10.1136/bmjopen-2019-031606 article EN cc-by BMJ Open 2019-08-01

Sleep disturbance is common and problematic for young people at ultra-high risk of psychosis. disruption a contributory causal factor in the occurrence mental health problems, including psychotic experiences, anxiety, depression. The implication that treating sleep problems might have additional benefits on outcomes individuals high risk. present study had two aims: first, to establish feasibility acceptability randomised controlled trial treat with aim reducing experiences psychosis;...

10.1016/s2215-0366(23)00203-1 article EN cc-by The Lancet Psychiatry 2023-08-07

Abstract Background Given the rapid expansion of research into digital health interventions (DHIs) for severe mental illness (SMI; eg, schizophrenia and other psychosis diagnoses), there is an emergent need clear safety measures. Currently, measurement reporting adverse events (AEs) are inconsistent across studies. Therefore, international network, iCharts, was assembled to systematically identify refine a set standard operating procedures (SOPs) AE in DHI studies SMI. Design The iCharts...

10.1093/schbul/sbae048 article EN cc-by Schizophrenia Bulletin 2024-04-29

Abstract Background Rapid weight gain is common with antipsychotic medication. Lost confidence, low mood and medication non‐adherence often follow. Yet, the dynamic interactions between physical psychological consequences of gain, implications for intervention, are unknown. Objectives We examined first‐person accounts to identify preferences change interventions. Design A qualitative design was used explore patients’ experiences in context psychosis. Method Semi‐structured interviews,...

10.1111/papt.12386 article EN Psychology and Psychotherapy Theory Research and Practice 2022-02-08

Automated virtual reality (VR) therapy has the potential to substantially increase access evidence-based psychological treatments. The results of a multicenter randomized controlled trial showed that gameChange VR cognitive reduces agoraphobic avoidance people diagnosed with psychosis, especially for those severe avoidance.We set out use peer research approach explore participants' experiences therapy. This in-depth experiential exploration user experience may inform implementation in...

10.2196/38065 article EN cc-by JMIR Serious Games 2023-01-16

Automated virtual reality therapies are being developed to increase access psychological interventions. We assessed the experience with one such therapy of patients diagnosed psychosis, including satisfaction, side effects, and positive experiences technology. tested whether effects affected therapy.In a clinical trial 122 psychosis completed baseline measures psychiatric symptoms, received gameChange VR therapy, then satisfaction questionnaire, Oxford-VR Side Effects Checklist, outcome...

10.1017/s0033291722001167 article EN cc-by Psychological Medicine 2022-04-28

This paper describes how participatory design was employed in the of an automated Virtual Reality (VR) psychological therapy (gameChange), putting people with lived experience psychosis at heart process. Solutions to complex challenges invariably need include expertise and ideas specialists from a broad variety disciplines experiences. The gameChange relied on insights clinical psychologists, programmers, animators, designers, product managers, producers, writers, researchers, 3 D artists,...

10.1080/24735132.2021.1885889 article EN cc-by Design for Health 2021-02-26

An automated virtual reality cognitive therapy (gameChange) has demonstrated its effectiveness to treat agoraphobia in patients with psychosis, especially for high or severe anxious avoidance. Its economic value the health care system is not yet established.

10.2196/39248 article EN cc-by Journal of Medical Internet Research 2022-11-18

Cognitive Bias Modification for paranoia (CBM-pa) is a novel, theory-driven psychological intervention targeting the biased interpretation of emotional ambiguity associated with paranoia. Study objectives were (i) test intervention's feasibility, (ii) provide effect size estimates, (iii) assess dose-response and (iv) select primary outcomes future trials.In double-blind randomised controlled trial, sixty-three outpatients clinically significant to either CBM-pa or an active control (text...

10.1017/s0033291722001520 article EN cc-by Psychological Medicine 2022-06-14

Background Paranoia is a highly debilitating mental health condition. One novel intervention for paranoia cognitive bias modification (CBM-pa). CBM-pa comes from class of interventions that focus on manipulating interpretation bias. Here, we aimed to develop and evaluate new therapy content later use in self-administered digital therapeutic called STOP (“Successful Treatment Paranoia”). Objective This study (1) take user-centered approach with input living experts, clinicians, academics...

10.2196/45453 article EN cc-by JMIR Human Factors 2023-09-23

Background Patients diagnosed with psychosis often spend less time than others engaged in exercise and more sitting down, which likely contributes to poorer physical mental health. Objective The aim of this study was develop a comprehensive framework from the perspective patients, carers, staff for understanding what promotes movement activity. Methods A critical realist approach taken design study. Interviews (n=23) focus groups (n=12) were conducted (1) outpatients aged 16 years or older...

10.1136/bmjment-2023-300878 article EN cc-by-nc BMJ Mental Health 2024-01-01

Adverse events (AEs) are commonly reported in clinical studies using the Medical Dictionary for Regulatory Activities (MedDRA), an international standard drug safety monitoring. However, technical language of MedDRA makes it challenging patients and clinicians to share understanding therefore make shared decisions about medical interventions. In this project, people with lived experience depression antidepressant treatment worked researchers co-design online dictionary AEs associated...

10.1186/s12888-024-05950-6 article EN cc-by BMC Psychiatry 2024-07-25

Persecutory delusions are the most common type of in psychosis and present around 10–15% general population. thought to be sustained by biased cognitive emotional processes. Recent advances favour targeted interventions, focussing on specific symptoms or mechanisms. Our aim is test clinical feasibility a novel psychological intervention, which manipulates interpretations toward more adaptive processing, order reduce paranoia patients. The 'Cognitive Bias Modification for paranoia' (CBM-pa)...

10.1186/s13063-017-2037-x article EN cc-by Trials 2017-06-29
Coming Soon ...